SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.¹ When a damaging force is placed on the line, SafeBreak intentionally separates to remove the force and protect the patient's IV. When separation occurs, valves on both ends of the device close to prevent medication leakage from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.1
"Lineus Medical continues to innovate and be the thought leader both clinically and scientifically in the breakaway device market," said Vance Clement, CEO of Lineus Medical. "SafeBreak Gen 2 will move us closer to accomplishing our mission of removing the pains associated with IV lines for patients, nurses, and hospitals."
"The SafeBreak Gen 2 design reflects our ongoing commitment to the continuous improvement of SafeBreak," said Will Armstrong, COO of Lineus Medical. "This patent showcases how our engineering team is advancing breakaway device technology with smarter, simpler design solutions that improve patient care while further strengthening the company's intellectual property portfolio."
About Lineus Medical
Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on file.
Photos: (Click photo to enlarge)
Source: Lineus Medical
Read Full Story - Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2 | More news from this source
Press release distribution by PRLog
